Position in SPRY
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$5,815,478
-$3,644,741 QoQ
Shares Held
724,219
-10.8% QoQ
Ownership
0.729%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SPRY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GOLDMAN SACHS GROUP INC holds $10,294,260,512 across 365 Biotechnology names. SPRY ranks #171 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,417,875 | $1,079,677,898 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,300,558 | $1,004,863,129 | |
| 3 | MRNA |
Moderna, Inc.
|
6,603,697 | $335,467,805 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
11,111,591 | $307,791,069 | |
| 5 | PRAX |
Praxis Precision Medicines, Inc.
|
710,734 | $228,991,385 | |
| 6 | INCY |
Incyte Corp
|
2,351,221 | $221,296,919 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
2,185,500 | $212,539,874 | |
| 8 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,965,432 | $170,933,620 |
All Filings in SPRY
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,815,478 | 724,219 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $9,460,219 | 812,036 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $13,323,676 | 1,325,739 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $25,552,244 | 1,464,312 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $9,031,848 | 717,953 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $9,348,534 | 886,117 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $3,999,897 | 275,855 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $3,750,688 | 440,739 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $4,728,957 | 462,716 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $773,233 | 141,101 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $905,112 | 239,448 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $825,125 | 123,153 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $1,279,240 | 196,504 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $962,994 | 112,895 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $526,162 | 99,652 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $522,732 | 123,286 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $356,934 | 101,691 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $521,031 | 78,233 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $542,402 | 54,349 | Shares | Defined | 2022-01-20 | |
| 2020-12-31 | $4,069,254 | 87,813 | Shares | Defined | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||